![]() |
市场调查报告书
商品编码
1827727
2025年全球心电图设备市场报告ECG Devices Global Market Report 2025 |
近年来,心电图设备市场规模快速扩张,从2024年的65.6亿美元成长到2025年的73.9亿美元,复合年增长率达12.6%。这段时期的成长动力源自于心血管疾病发病率的上升、人口老化、诊断和监测需求的增加、医疗基础设施的建设、远端医疗和远端监测以及居家医疗等因素。
预计未来几年心电图设备市场规模将快速成长,到2029年将达到122.2亿美元,复合年增长率为13.4%。预测期内的增长可归因于心律不整早期检测的增加、连线健诊医疗和治疗、对互联健康生态系统日益增长的需求、新兴市场的扩张、非侵入性心臟监测以及疫情后对医疗保健的关注。预测期内的主要趋势包括可携式和穿戴式心电图设备、远端医疗和远距会诊中的心电图、人工智慧和机器学习的整合、技术进步以及医疗物联网的普及。
心电图 (ECG) 是一种诊断程序,它记录心臟电讯号,以监测心臟功能并检测潜在的心血管健康问题。这些设备在诊断应用中发挥重要作用。
心电图设备市场主要包含两大产品类型:监测心电图系统和诊断心电图系统。监测心电图系统旨在记录心臟电讯号,并用于评估各种心臟状况。这些系统提供多种导极类型,包括单导联心电图、3 至 6 导程心电图和 12 导程心电图,并采用多种技术,包括可携式和无线心电图系统。监测心电图系统广泛应用于各个领域,包括医院、居家照护机构和其他医疗保健环境。
2025年春季美国关税大幅上调及其引发的贸易摩擦对医疗设备产业产生了重大影响,尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战进一步加剧了形势,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场准入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供心电图设备市场统计数据,例如全球市场规模、区域份额、竞争对手的市场份额、详细的心电图设备细分市场、市场趋势和商业机会,以及您在心电图设备行业取得成功所需的数据。本心电图设备市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
我们对该市场未来五年13.4%的成长率预测与先前保持不变。下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自荷兰和新加坡等主要地区的高解析度类比前端晶片和触控萤幕征收关税直接影响美国,从而导致心臟诊断能力下降和设备采购成本上升。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,影响也将更加广泛。
心血管疾病盛行率的上升预计将在未来几年推动心电图设备市场的成长。心血管疾病是全球最常见的健康问题之一,也是导致死亡的主要原因。心电图 (ECG 或 EKG) 透过测量心臟产生的电讯号来检测各种心臟状况。电极连接到胸部以记录这些负责心率的电讯号。例如,2024 年 5 月,美国政府机构疾病管制与预防中心 (CDC) 报告称,2022 年心臟病将导緻美国702,880 人死亡,占死亡人数的五分之一。因此,高血压心臟疾病、中风、周边动脉疾病和缺血性心臟疾病(IHD) 等心血管疾病盛行率的不断上升正在推动预测期内心电图设备市场的成长。
预计未来几年,医疗保健支出的增加将推动心电图设备市场的成长。医疗保健支出的增加通常会带来医学研发资金的增加,从而促进心电图设备在初级保健机构(尤其是在发展中地区和国家)的广泛应用。例如,2023年5月,英国国家统计局(政府机构)报告称,英国的医疗保健支出将达到约3548.8亿美元(2830亿英镑),较2021年名义增加0.7%。因此,医疗保健支出的增加预计将促进心电图设备市场的扩张。
技术进步已成为心电图设备市场的关键趋势,主要企业专注于开发尖端解决方案以保持其市场地位。 2022 年 1 月,总部位于荷兰的企业集团荷兰皇家飞利浦公司推出了一种家用 12 导程心电图 (ECG) 解决方案,旨在分散临床试验。这种创新的解决方案允许临床试验参与者使用 PCA 500 ECG 贴片资料记录技术在家中记录与中心 ECG 相当的高品质资料。此解决方案的体戴式贴片可实现合规的 12 导联 ECG 和近乎即时、高度安全的资料传输,而无需频繁的现场访问、临床实验技术人员或访问护理师。预计这项技术进步将促进 ECG 设备市场的成长。
心电图设备市场的主要企业正策略性地专注于推出心臟监测贴片,以此作为竞争优势。这些医疗设备也称为心臟心臟事件记录器或心臟心电图监测,可长时间持续监测患者的心臟活动。例如,2022 年 8 月,瑞士医疗设备製造商 SmartCardia SA 宣布在印度市场推出 7 导程心臟监测贴片 7L。这种创新的贴片将医疗穿戴式技术与人工智慧 (AI) 相结合,透过远端监控提供预测性和个人化的患者见解。 7L 贴片由 SmartCardia 的 AI 平台跟踪,并由委员会认证的心臟病专家和循环系统进行解读,可即时检测关键心律失常事件,其准确度可与循环系统相媲美。
2024年5月,日本医疗设备製造商欧姆龙医疗(OMRON Healthcare)与AliveCor合作,推出一款用于早期发现和管理心臟病的可携式心电图设备,旨在改善印度的心血管健康监测。这家总部位于美国的医疗设备公司AliveCor允许用户透过智慧型手机应用程式方便地记录和监测心臟活动。
心电图设备市场的主要企业包括 GE Healthcare Technologies Inc.、Koninklijke Philips NV、Spacelabs Healthcare Inc.、CardioNet LLC、Schiller AG、Nihon Kohden Corporation、Medtronic plc、OSI Systems Inc.、深圳生物医疗电子有限公司、Hill-Rom Holdings Inc.、BPL Medical Technologies Private Limited、MortNA Technologies PrivateS. Co.Ltd.、Cardiac Science Corporation、Midmark Corporation、Omron Healthcare Inc.、Abbott Laboratories、AliveCor Inc.、Compumedics Limited、BioTelemetry Inc.、Welch Allyn Inc.、Natus Medical Incorporated、Innomed Medical & Develoshi and Manufacturing Ltd.、BIoTronik Ltd. Inc.Ltd.、Spacelabs Healthcare、Medical International Limited、深圳生物医疗电子有限公司等。
2024年心电图设备市场最大的地区是北美。预计亚太地区将成为预测期内心电图设备市场成长最快的地区。心电图设备市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。
心电图设备市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。
心电图设备市场包括监视器、电极、扩大机和导联线的销售。该市场的价值指的是“出厂价”,即商品製造商或生产商向其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。
An Electrocardiogram (ECG) is a diagnostic procedure that involves recording the heart's electrical signals to monitor its function and detect potential cardiovascular health issues. These devices play a crucial role in diagnostic applications.
The ECG devices market primarily consists of two main product types such as monitoring ECG systems and diagnostic ECG systems. Monitoring ECG systems are designed to record the heart's electrical signals, allowing for the assessment of various cardiac conditions. These systems come in different lead types, including single-lead ECG, 3-6 lead ECG, and 12-Lead ECG, and utilize diverse technologies such as portable and wireless ECG systems. The implementation of monitoring ECG systems is widespread across various sectors, including hospitals, home care settings, and other healthcare environments.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The ECG devices market research report is one of a series of new reports from The Business Research Company that provides ECG devices market statistics, including ECG devices industry global market size, regional shares, competitors with a ECG devices market share, detailed ECG devices market segments, market trends and opportunities, and any further data you may need to thrive in the ECG devices industry. This ECG devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ecg devices market size has grown rapidly in recent years. It will grow from $6.56 billion in 2024 to $7.39 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to cardiovascular disease prevalence, aging population, diagnostic and monitoring needs, healthcare infrastructure growth, telemedicine and remote monitoring, and home-based healthcare.
The ecg devices market size is expected to see rapid growth in the next few years. It will grow to $12.22 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing early detection of cardiac arrhythmias, personalized medicine and treatment, growing need for connected health ecosystem, emerging market expansion, non-invasive cardiac monitoring, and post-pandemic healthcare focus. Major trends in the forecast period include portable and wearable ecg devices, ecg in telehealth and remote consultations, ai and machine learning integration, technological advancements, and healthcare iot adoption.
The forecast of 13.4% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on high-resolution analog front-end chips and touchscreen displays, sourced from key regions such as the Netherlands and Singapore, which could lead to reduced cardiac diagnostic capabilities and higher equipment procurement expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of cardiovascular diseases is anticipated to drive the growth of the ECG devices market in the coming years. Cardiovascular disease is one of the most prevalent health issues and is the leading cause of death worldwide. An electrocardiogram (ECG or EKG) is used to detect various cardiac conditions by measuring the electrical signals generated by the heart. Electrodes are placed on the chest to record these electrical signals, which are responsible for the heartbeat. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that heart disease accounted for 702,880 deaths in the United States in 2022, representing 1 in every 5 deaths. Therefore, the increasing prevalence of cardiovascular diseases, including hypertensive heart disease, stroke, peripheral artery diseases, and ischemic heart disease (IHD), is driving the growth of the ECG devices market during the forecast period.
The rise in healthcare expenditure is anticipated to drive the growth of the ECG devices market in the future. Higher healthcare spending often leads to increased funding for medical research and development, facilitating the widespread adoption of ECG devices in primary healthcare settings, especially in developing regions and countries. For example, in May 2023, the Office for National Statistics, a UK-based government department, reported that healthcare expenditure in the UK amounted to approximately $354.88 billion (£283 billion), reflecting a nominal increase of 0.7% from 2021. Therefore, the growing healthcare expenditure is expected to contribute to the expansion of the ECG devices market.
Technological advancements emerge as a significant trend in the ECG devices market, with major companies focusing on developing cutting-edge solutions to maintain their market positions. In January 2022, Royal Philips, a Netherlands-based conglomerate corporation, introduced an at-home 12-lead electrocardiogram (ECG) solution designed for use in decentralized clinical trials. This innovative solution enables clinical trial participants to record high-quality data at home, comparable to site-based ECGs, utilizing PCA 500 ECG patch data recording technology. The solution's body-worn patch allows compliant 12-lead ECG implementation and near-real-time, highly secure data transfer without the need for frequent site visits, onsite technicians, or home nurses. This technological advancement is anticipated to contribute to the growth of the ECG devices market.
Major players in the ECG devices market are strategically emphasizing the introduction of cardiac monitoring patches as a key competitive advantage. Also known as cardiac event monitors or cardiac Holter monitors, these medical devices offer continuous monitoring of a patient's heart activity over an extended duration. For instance, in August 2022, SmartCardia SA, a Swiss medical equipment manufacturer, unveiled its 7L patch, a 7-lead cardiac monitoring patch introduced in the Indian market. This innovative patch integrates medical wearable technology with artificial intelligence (AI) to deliver predictive and personalized patient insights through remote monitoring. Tracked by SmartCardia's AI platform and interpreted by certified cardiac technicians and cardiologists, the 7L patch achieves real-time detection of significant arrhythmia events at a level of accuracy comparable to that of cardiologists.
In May 2024, OMRON Healthcare, a Japan-based medical equipment firm, partnered with AliveCor. This collaboration aims to improve cardiovascular health monitoring in India by introducing portable ECG devices designed for the early detection and management of heart diseases. AliveCor, a US-based medical device company, enables users to conveniently record and monitor their heart activity through a smartphone app.
Major companies operating in the ECG devices market include GE Healthcare Technologies Inc., Koninklijke Philips N.V., Spacelabs Healthcare Inc., CardioNet LLC, Schiller AG, Nihon Kohden Corporation, Medtronic plc, OSI Systems Inc., Shenzhen Bio-Medical Electronics Co. Ltd., Hill-Rom Holdings Inc., BPL Medical Technologies Private Limited, Mortara Instrument Inc., General Electric Company, Opto Circuits Limited, Bionet Co. Ltd., Cardiac Science Corporation, Midmark Corporation, Omron Healthcare Inc., Abbott Laboratories, AliveCor Inc., Compumedics Limited, BioTelemetry Inc., Welch Allyn Inc., Natus Medical Incorporated, Innomed Medical Developing and Manufacturing Ltd., Biotronik SE & Co. KG, Fukuda Denshi Co. Ltd., Spacelabs Healthcare, Medical International Limited, Shenzhen Bio-Medical Electronics Co. Ltd.
North America was the largest region in the ECG devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the ECG devices market during the forecast period. The regions covered in the ECG devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the ECG devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The ECG devices market consists of sales of monitors, electrodes, amplifiers, and leads. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
ECG Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ecg devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ecg devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ecg devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.